Journal
WORLD JOURNAL OF CLINICAL ONCOLOGY
Volume 9, Issue 8, Pages 180-187Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.5306/wjco.v9.i8.180
Keywords
Cellular senescence; Cancer treatment; Chemotherapy; Ionizing radiation; Cyclin-dependent kinases 4/6 inhibitor; Aurora kinase inhibitor; Immunotherapy; T helper-1 cells; T helper-1 cytokines
Categories
Funding
- NIGMS NIH HHS [P20 GM103542] Funding Source: Medline
Ask authors/readers for more resources
Cellular senescence is a form of permanent cell cycle arrest that can be triggered by a variety of cell-intrinsic and extrinsic stimuli, including telomere shortening, DNA damage, oxidative stress, and exposure to chemotherapeutic agents and ionizing radiation. Although the induction of apoptotic cell death is a desirable outcome in cancer therapy, mutations and/or deficiencies in the apoptotic signaling pathways have been frequently identified in many human cancer types, suggesting the importance of alternative apoptosis-independent therapeutic approaches for cancer treatment. A growing body of evidence has documented that senescence induction in tumor cells is a frequent response to many anticancer modalities including cyclin-dependent kinases 4/6 small molecule inhibitor-based targeted therapeutics and T helper-1 cytokine-mediated immunotherapy. This review discusses the recent advances and clinical relevance of therapy-induced senescence in cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available